Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?

2021 ◽  
Author(s):  
C. A. Pereda ◽  
M. B. Nishishinya-Aquino ◽  
N. Brito-García ◽  
P. Díaz del Campo Fontecha ◽  
I. Rua-Figueroa
Keyword(s):  
Rheumatic Diseases ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia ◽  
Cotrimoxazole Prophylaxis ◽  
Autoimmune Rheumatic Diseases

scholarly journals Pneumocystis jirovecii Pneumonia in Patients with Rheumatic Diseases: Risk Assessment and Prophylaxis

2022 ◽  
pp. 1-7
Author(s):  
Matthew Shing Him Lee ◽  
Shirley Chiu Wai Chan
Keyword(s):  
Risk Factors ◽  
Risk Assessment ◽  
Rheumatic Diseases ◽  
Immunosuppressive Agents ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia ◽  
International Guideline ◽  
Related Factors ◽  
Factors Associated ◽  
Disease Specific

Pneumocystis jirovecii pneumonia (PJP) is an uncommon opportunistic infection in patients with rheumatic diseases with high mortality. Unlike other non-HIV conditions, international guideline for PJP prophylaxis in rheumatic diseases is currently lacking. Recent evidence regarding the risk of PJP and effectiveness of prophylaxis has been accumulating. This Review provides an update on the information about risk factors associated with PJP in patients with rheumatic diseases based on rheumatic diagnoses, use of immunosuppressive agents and other disease-related factors. The second part of the article summarizes evidence regarding the effectiveness of PJP prophylaxis by considering both disease-related and therapy-related factors. Finally, the Review outlined the currently available disease-specific recommendations and local guidelines, and appreciate the factors that influence physicians’ decision.

scholarly journals Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs

2019 ◽  
Vol 48 (6) ◽  
pp. 1087-1092 ◽  
Author(s):  
Gabriela Schmajuk ◽  
Kashif Jafri ◽  
Michael Evans ◽  
Stephen Shiboski ◽  
Milena Gianfrancesco ◽  
...  
Keyword(s):  
High Risk ◽  
Rheumatic Diseases ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia

scholarly journals Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Rheumatic Diseases

2019 ◽  
Vol 20 (-1) ◽  
pp. 122-122
Author(s):  
Imren Nesil ◽  
◽  
Pervin Korkmaz Ekren ◽  
Figen Yargucu Zihni ◽  
Adnan Yuksel Guruz ◽  
...  
Keyword(s):  
Risk Factors ◽  
Rheumatic Diseases ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia
Sign in / Sign up

Export Citation Format

Share Document